Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmonary effect of bronchodilation in adult ventricular septal defect patients
2015-005507-89Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of salbutamol in Ventricular Septal Defect (VSD) (3 arms), sponsored by Aarhus University Hospital. Primary endpoint: Peak minute ventilation. Started Jun 2016; status: completed.
02
Drugs
salbutamol
03
Conditions
Ventricular Septal Defect (VSD)
Beyond the preview
Go deeper on 2015-005507-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005507-89.